Latham & Watkins Advises KKR on Qventus' $105 Million Investment.
Qventus, a leader in AI-driven care automation software for healthcare systems, has secured a significant $105 million investment to further expand its AI-based platform. The funding, led by global investment firm KKR, includes participation from Bessemer Venture Partners and strategic health system investors such as Northwestern Medicine, HonorHealth, and Allina Health.
The funding will help Qventus enhance its AI-driven automations and operational assistants across a wider range of healthcare settings, improving both inpatient and outpatient care. This will include expanding the company's existing products like the Surgical Growth and Inpatient Capacity solutions, along with introducing new innovations from its AI Operational Assistants platform.
Mudit Garg, CEO and Co-Founder of Qventus, said, “Across the country, healthcare teams have to do extraordinary things to get ordinary things done every single day. Qventus has dedicated the last decade to building AI automation solutions that alleviate the administrative burden of healthcare staff so they can deliver highly reliable patient care. This funding is a testament to how these solutions generate best-in-industry return on investment, helping health systems achieve the margins needed to fulfill their mission of delivering exceptional care to their communities. This capital primes us to continue maximizing our growth, delivering on our promises to our partners, and launching new, game-changing technology.”
Jake Heller, Partner at KKR, also praised Qventus’s position, commenting, “Built on a solid foundation, Qventus has navigated the evolving care landscape and emerged resilient, thanks to its sophisticated technology and proprietary data engine built over the last decade. We believe Qventus is well-positioned to be a market leader in supporting care delivery at the provider level and redefining the future of health care by supporting hospital systems in operating more efficiently so they can focus on what really matters–quality care for patients.”
Northwestern Medicine’s Doug King highlighted the benefits of Qventus’s AI-powered solutions, saying, “By deploying Qventus’ solutions, Northwestern Medicine is able to reduce the burden on our clinical teams and allow them to turn their focus to caring for our patients.”
Latham & Watkins advised KKR in the transaction, with corporate deal team leaders Ryan McCarthy and John Miller, alongside associates Michael Casagrande and Cherrie Wang. Additional guidance was provided on intellectual property by Sarah Gagan, with associates Deborah Hinck, Victoria Allen, and Daniel Barks; on data privacy by Heather Deixler and Priyanka Krishnamurthy; on compensation and benefits by Josh Friedman and Tessa Young; on tax by Katharine Moir and Abigail Friedman; and on antitrust by Ian Conner.
Latham & Watkins LLP is a leading global law firm known for its expertise in corporate, litigation, and transactional law. With over 2,000 attorneys in 14 countries, the firm advises clients across a wide range of industries, including technology, healthcare, finance, and energy. Founded in 1934, Latham & Watkins is renowned for its work with emerging companies, offering legal solutions for startups and growth-stage businesses. The firm’s Emerging Companies & Growth team helps navigate complex legal matters related to business formation, financing, and scaling, making it a trusted partner for innovative companies worldwide.
